🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.640
-0.051 (-3.02%)
Nov 20, 2026, 5:29 PM CET

Oncopeptides AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
116.8482.26178.54173.41344.52362.19
Short-Term Investments
---0.030.352.11
Cash & Short-Term Investments
116.8482.26178.54173.44344.86364.3
Cash Growth
-21.01%-53.93%2.94%-49.71%-5.33%-57.27%
Accounts Receivable
34.57.777.292.190.6711.87
Other Receivables
-8.676.2415.6816.2524.01
Receivables
34.516.4313.5317.8716.9235.89
Inventory
13.368.244.372.43--
Prepaid Expenses
-5.346.195.431.717.42
Other Current Assets
-5.279.963.730.544.76
Total Current Assets
164.7117.72217.08202.9364.03412.37
Property, Plant & Equipment
11.1817.6827.1134.6320.4424.74
Other Intangible Assets
-----1.41
Other Long-Term Assets
0--00.850.850.85
Total Assets
175.87135.4244.19238.38385.32439.38

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
11.760.718.1715.0328.2235.7
Accrued Expenses
-28.3215.1220.3817.2436.61
Current Portion of Leases
-7.727.275.13610.99
Current Income Taxes Payable
-1.151.730.580.30.05
Current Unearned Revenue
-0.230.070.5--
Other Current Liabilities
32.166.934.663.3233.91141.94
Total Current Liabilities
43.9245.0651.3644.9385.67225.29
Long-Term Debt
140.42126.68121.89106.49--
Long-Term Leases
-4.9812.5519.67-3.21
Other Long-Term Liabilities
8.0317.564.1110.515.360.01
Total Liabilities
192.37194.29189.91181.691.03228.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
43.9230.323.9110.5110.488.37
Additional Paid-In Capital
-5,8145,6845,4145,4034,982
Retained Earnings
--5,900-5,651-5,366-5,116-4,778
Comprehensive Income & Other
-60.42-3.21-2.84-2.2-2.3-0.92
Shareholders' Equity
-16.5-58.8954.2956.78294.29210.87
Total Liabilities & Equity
175.87135.4244.19238.38385.32439.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
140.42139.39141.72131.29614.19
Net Cash (Debt)
-23.58-57.1336.8242.15338.86350.11
Net Cash Growth
---12.65%-87.56%-3.21%-57.98%
Net Cash Per Share
-0.07-0.250.220.474.124.65
Filing Date Shares Outstanding
395.29272.71215.1994.694.3175.29
Total Common Shares Outstanding
395.29272.71215.1994.694.3175.29
Working Capital
120.7872.66165.73157.97278.36187.08
Book Value Per Share
-0.04-0.220.250.603.122.80
Tangible Book Value
-16.5-58.8954.2956.78294.29209.46
Tangible Book Value Per Share
-0.04-0.220.250.603.122.78
Machinery
-16.4616.4616.115.9914.42